Current stock page

News

VRDN Stock News

Headlines · Sentiment · Source Context · AIQ Market Impact

HealthcareBiotechnologyScore data as of Nov 13, 2026

VRDNViridian Therapeutics, Inc.

Healthcare / Biotechnology

Low Priority

Above Peers

NeutralEdge 6/10
$30.87+$0.39 (+1.28%)

Latest quote

  • Momentum
    91
  • Value
    37
  • Quality
    41
  • Risk resilience
    46
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

VRDN News

Viridian Therapeutics, Inc. latest headlines and updates

News Sentiment
No recent news found for VRDN
News limit reached for Free plan
Upgrade to Pro for full news feed access and deeper AI insights.
Upgrade to Pro
See how news sentiment affects the AIQ Score
Review news alongside the complete analysis workspace.

VRDN News FAQ

What is the latest VRDN stock news?

The latest VRDN stock news appears on this page when current headlines are available. Use news with price movement, sentiment, AIQ Score, and upcoming catalysts.

Why is VRDN stock up today?

VRDN's daily move can be affected by earnings, guidance, analyst actions, sector news, macro data, or company-specific headlines. Check the current news feed and sentiment before assigning a cause.

What news is affecting VRDN stock today?

News affecting VRDN today may include earnings updates, price-target changes, product developments, regulatory items, or sector moves. Confirm whether the news is material or just short-term noise.

What should VRDN investors watch next?

VRDN investors should watch the next earnings update, analyst revisions, material company news, AIQ momentum, and risk changes. Fresh news matters most when it changes estimates or trend quality.